Ovid Therapeutics (OVID) Asset Utilization Ratio (2021 - 2026)

Ovid Therapeutics has reported Asset Utilization Ratio for 6 years, with the latest figure at 0.04 in Q1 2026.

• For the quarter ending Q1 2026, Asset Utilization Ratio rose 499.91% year-over-year to 0.04; the trailing twelve-month figure through Mar 2026 stood at 0.04 (up 499.91% YoY), and the FY2025 full-year result was 0.06, up 1144.87% from the prior year.
• Asset Utilization Ratio for Q1 2026 stood at 0.04, down from 0.07 in the prior quarter.
• The five-year high for Asset Utilization Ratio was 0.09 in Q3 2025, with the low at 0.0 in Q1 2023.
• Historically, Asset Utilization Ratio has averaged 0.02 across 5 years, with a median of 0.01 in 2022.
• Annual changes were most pronounced in 2022 — Asset Utilization Ratio sank 99.5% — and 2025, when it surged 1738.0%.
• Ovid Therapeutics' Asset Utilization Ratio stood at 0.01 in 2022, then plunged by 51.26% to 0.0 in 2023, then soared by 99.41% to 0.01 in 2024, then jumped by 1062.2% to 0.07 in 2025, then plunged by 43.98% to 0.04 in 2026.
• The last three Asset Utilization Ratio figures came in at 0.04 (Q1 2026), 0.07 (Q4 2025), and 0.09 (Q3 2025), per Business Quant data.